Published 5 hours ago • loading... • Updated 39 minutes ago
Trump’s sanctions, inflation and a collapsing economy leaves Iran’s sick exposed
More than 18,000 pharmacies await insurance payments as shortages hit nearly 800 medicines and patients cut doses or delay treatment, officials said.
In Tehran, 35-year-old Sima and other patients face severe medicine shortages affecting almost 800 medications as inflation drives prices beyond reach. The Iranian Pharmacists Association reports pharmacies cannot procure alternatives due to rising costs.
US sanctions and banking 'overcompliance' have impeded pharmaceutical imports, as institutions fear processing transactions involving Iran. Treasury Secretary Scott Bessent tightened license rules last week, adopting a "presumed denial" stance that discourages international firms from doing business.
More than 18,000 private pharmacies await payment, with insurance debts reaching $300 million. Airstrikes earlier this year damaged more than 40 pharmaceutical companies, yet Iran manufactures more than 97% of its medicines by volume, leaving the supply chain caught between debt and destruction.
Cancer patients are selling household items to afford medication, while a 55-year-old cancer patient described the struggle as "running out of options." Others ration supplies, with one patient saying, "I don't know if being brave means anything when you're dying."
Iran is negotiating with the US to unfreeze humanitarian funds held in Qatar to facilitate medical trade. Experts warn, however, that the complex sanctions framework continues to complicate procurement for the Islamic Republic.